Literature DB >> 20691941

Restricted diffusion in the corpus callosum in hypoxic-ischemic encephalopathy.

Toshiki Takenouchi1, Linda A Heier, Murray Engel, Jeffrey M Perlman.   

Abstract

Restricted diffusion within the splenium of the corpus callosum was described in various conditions, but is not a prominent finding in magnetic resonance imaging after neonatal hypoxic-ischemic encephalopathy. Perinatal characteristics were reviewed in 42 term neonates with hypoxic-ischemic encephalopathy treated with selective head cooling. Neonatal images of 34 infants were reviewed. Ten of 34 (29%) infants demonstrated restricted diffusion changes within the splenium of the corpus callosum, with a significantly higher incidence of death or severe developmental delay, compared with infants without changes in the splenium of the corpus callosum (n = 24) (P = 0.002). The positive predictive value of changes in the splenium of the corpus callosum regarding poor outcomes or death was 90%. Changes in the splenium of the corpus callosum were also associated with lower birth weights, larger base deficits in cord arterial gas, and more severe encephalopathy during enrollment in selective head cooling. Restricted diffusion within the splenium of the corpus callosum of term infants with hypoxic-ischemic encephalopathy is often associated with extensive brain injury, and in these circumstances appears to be an early neuroradiologic marker of adverse neurologic outcomes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20691941     DOI: 10.1016/j.pediatrneurol.2010.04.014

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  9 in total

1.  Abnormal corpus callosum in neonates after hypoxic-ischemic injury.

Authors:  Monica Epelman; Alan Daneman; William Halliday; Hilary Whyte; Susan I Blaser
Journal:  Pediatr Radiol       Date:  2011-09-21

2.  Hypothermia-treated neonates with hypoxic-ischemic encephalopathy: Optimal timing of quantitative ADC measurement to predict disease severity.

Authors:  Yauk K Lee; Alex Penn; Mahesh Patel; Rajul Pandit; Dongli Song; Bo Yoon Ha
Journal:  Neuroradiol J       Date:  2016-11-23

Review 3.  Diffusion tensor imaging for understanding brain development in early life.

Authors:  Anqi Qiu; Susumu Mori; Michael I Miller
Journal:  Annu Rev Psychol       Date:  2015-01-03       Impact factor: 24.137

4.  Quantitative cranial magnetic resonance imaging in neonatal hypoxic-ischemic encephalopathy.

Authors:  Sarah B Mulkey; Vivien L Yap; Christopher J Swearingen; Melissa S Riggins; Jeffrey R Kaiser; G Bradley Schaefer
Journal:  Pediatr Neurol       Date:  2012-08       Impact factor: 3.372

5.  Comparing tract-based spatial statistics and manual region-of-Interest labeling as diffusion analysis methods to detect white matter abnormalities in infants with hypoxic-Ischemic encephalopathy.

Authors:  Monica T Ly; Tania U Nanavati; Christopher A Frum; Paola Pergami
Journal:  J Magn Reson Imaging       Date:  2015-04-24       Impact factor: 4.813

Review 6.  Pediatric brain injury: can DTI scalars predict functional outcome?

Authors:  Duan Xu; Pratik Mukherjee; A James Barkovich
Journal:  Pediatr Radiol       Date:  2013-01-04

7.  Therapeutic hypothermia modifies perinatal asphyxia-induced changes of the corpus callosum and outcome in neonates.

Authors:  Thomas Alderliesten; Linda S de Vries; Yara Khalil; Ingrid C van Haastert; Manon J N L Benders; Corine Koopman-Esseboom; Floris Groenendaal
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

8.  Restricted diffusion in the corpus callosum: A neuroradiological marker in hypoxic-ischemic encephalopathy.

Authors:  Alok Kale; Priscilla Joshi; A B Kelkar
Journal:  Indian J Radiol Imaging       Date:  2016 Oct-Dec

Review 9.  The splenium of the corpus callosum: embryology, anatomy, function and imaging with pathophysiological hypothesis.

Authors:  J Blaauw; L C Meiners
Journal:  Neuroradiology       Date:  2020-02-15       Impact factor: 2.804

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.